• In early May 2026, KKR reported first‑quarter results that beat earnings and revenue estimates, increased its dividend, expanded its share repurchase authorization to US$3.07 billion, and closed the US$1.40 billion acquisition of sports investor Arctos Partners.
• Together with fresh buyback capacity and growing fee‑earning assets, the Arctos deal signals KKR’s intent to build a broader, sports‑focused investment platform alongside its core alternatives franchise.
• We’ll now examine how KKR’s stronger‑than‑expected earnings and enlarged buyback authorization may influence its pre‑existing investment narrative.

Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

KKR Investment Narrative Recap

To own KKR, you need to be comfortable with a fee driven alternatives manager that leans heavily on fundraising, performance fees and capital deployment across private credit and asset based finance. The latest earnings beat, higher dividend and expanded US$3.07 billion buyback support the near term story that fee related earnings can offset a choppy monetization backdrop. The biggest risk remains that a tougher deal and exit market keeps realized performance income volatile, even as assets under management grow.

Among recent announcements, the enlarged buyback authorization stands out as most relevant. Since January, KKR has already repurchased 3.5 million shares for US$317 million, bringing total repurchases under its long running plan to 70.9 million shares, or 13.47 percent of the company. For a business whose key catalyst is earnings growth from rising fee paying assets, disciplined repurchases at lower prices can matter, but do not remove the underlying risks around private credit, ABF exposure and fundraising competition.

Yet against this stronger earnings and buyback story, investors should still pay close attention to how dependent KKR remains on sometimes volatile monetizations and...

KKR's narrative projects $13.7 billion revenue and $5.4 billion earnings by 2028. This requires a 13.9% yearly revenue decline and an earnings increase of about $3.4 billion from $2.0 billion today.

Uncover how KKR's forecasts yield a $140.24 fair value, a 39% upside to its current price.

Exploring Other Perspectives

Some analysts were far more optimistic before this news, expecting earnings to reach about US$5.6 billion by 2028, which assumes smoother deployment and stronger margins than the baseline narrative and highlights how differently you and other shareholders might weigh the same fundraising and performance fee risks once fresh results are in.

Explore 7 other fair value estimates on KKR - why the stock might be worth just $98.13!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your KKR research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free KKR research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate KKR's overall financial health at a glance.

Contemplating Other Strategies?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.